Rand Paul Late To Disclosing That His Wife Bought Stock in Company Behind COVID Drug
Sen. Rand Paul (R-Ky.) shared that his wife bought stock in the company behind the antiviral drug known as remdesivir, a drug used to treat COVID-19. According to The Washington Post , Kelley Paul invested in Gilead…
Sen. Rand Paul (R-Ky.) shared that his wife bought stock in the company behind the antiviral drug known as remdesivir, a drug used to treat COVID-19.
According to The Washington Post, Kelley Paul invested in Gilead Sciences on February 26, 2020, before the World Health Organization classified the virus as a pandemic.
The disclosure did not come until 16 months after the deadline set by the Stock Act of 45 days. The Stock Act is designed to stop insider trading.
A spokeswoman for the senator, Kelsey Cooper, saidRand Paul learned recently that a reporting form for his wife’s investment had not been transmitted. Cooper explained Rand Paul approached the Senate Ethics Committee for guidance.
She said he filed both the supplemental report and the annual disclosure on Wednesday. It was due in May. Kelley Paul reportedly lost money on the investment. She used her own earnings to invest.
James D. Cox, a professor of law at Duke University, told the Post, “The senator ought to have an explanation for the trade and, more importantly, why it took him almost a year and a half to discover it from his wife.”
The disclosure comes as Rand Paul